AOA Latest News                                                                                

View Video Conference on Personalized Medicine, Comparative Effectiveness Research

On October 19 and 20, the NIH, AHRQ, ECRI Institute, Kaiser Permanente Institute for Health Policy, Health Affairs, Milbank Memorial Fund, and the Leonard Davis Institute of the University of Pennsylvania will co-sponsor a major conference on the interface between personalized medicine and comparative effectiveness research. The conference will be available via live video stream and will be archived for viewing online at http://videocast.nih.gov/PastEvents.asp. Panels of physicians and scientists will discuss specific learning objectives about the present and future impact of personalized medicine and comparative effectiveness research on physicians and patients. updated Oct. 14

Bureau of Osteopathic History and Identity announces essay winners

The AOA Bureau of Osteopathic History and Identity has announced the winners of its sixth annual history essay competition. First place was awarded to Hayley W. Ryan, OMS II, a student at the Philadelphia College of Osteopathic Medicine, for her essay titled "Whatever You Are, Be a Good One." The essay examines the bureau's core principle 9: The political efforts of DOs to obtain equal licensure provisions and equal treatment with MDs under the law. Second place honors went to Derek H. Cheng, OMS II, of the New York College of Osteopathic Medicine of New York Institute of Technology in Old Westbury. Cheng's essay, "Osteopathic Medicine in the U.S. Military: The Battle for Equality and Distinction." focuses on the bureau’s core principle 16: "The factors leading to and the consequences of DOs being admitted to the uniformed services as physicians and surgeons." Visit The DO to learn more about the competition. updated Oct. 13

Register Today for OMED 2010 Unified

There's still time left to register for the 115th Osteopathic Medical Conference & Exposition, known as OMED 2010 Unified, which will be held in San Francisco from Sunday, Oct. 24, through Thursday, Oct. 28. This year's conference theme, "A Bridge to OpportUNITY," promotes teamwork among AOA official family members to advance shared goals and joint initiatives. OMED 2010 in San Francisco is an experience you don't want to miss. Visit the OMED 2010 Unified website to learn more about this important event and register today. Read a preview issue of OMED Daily News. updated Sept. 27

AOA Supports World Alzheimer's Day Efforts to Promote Early Detection

In honor of World Alzheimer's Day on Sept. 21, the AOA joins the Alzheimer's Association in asking all Americans to take action and join in the fight against this devastating disease. Because early detection is key to ensuring optimal treatment outcomes, the AOA has joined efforts with the Alzheimer's Association to provide physician resources for treating patients with Alzheimer's. Visit the Alzheimer's Online Education Center to learn more. updated Sept. 21

View the AOA's Latest Webinars on HIT and E-Prescribing of Controlled Substances

If you missed the recent AOA webinars on electronic health records (EHR) and e-prescribing of controlled substances, you can catch up on all the details by viewing replays of the events on DO-Online. Watch the replay as David Blumenthal, MD, walks you through how to qualify for the Medicare and Medicaid bonus program for implementation of an EHR. Listen as Cathy Gallagher of the Drug Enforcement Administration details the guidelines for electronic prescribing of controlled substances. Visit the DO-Online HIT Resource Center to view the webinars now. updated Sept. 9

Members Create Practice Websites, Visitors Get Health Info

The AOA and AOIA's newest member benefit, DoctorsOffice.net, is a website that combines a wealth of reliable, multimedia health information with attractive, functional practice websites for physician practices. Members and their practice partners can choose from 9 designs and create their own websites with easy-to-use templates. Members who created DO-Online practice websites in the past will find their sites already upgraded. Get started now, and create your new website in about 10 minutes. updated Aug. 25

FDA Issues Drug Warning for Seizure, Bipolar Disorder Medication

The U.S. Food and Drug Administration is informing the public that Lamictal (lamotrigine), a medication commonly used for seizures in children two years and older, and bipolar disorder in adults, can cause aseptic meningitis. The FDA is revising the Warnings and Precautions section of the drug label and the patient Medication Guide to include information about this risk. In most cases, patients' symptoms were reported to have resolved after Lamictal was discontinued. Additional information is available on the FDA website. updated Aug. 16

Archived News>>